Toggle menu

BreathSpec study

Start date:
December 2018
End date:
April 2019
Co-ordinated by:
Julia Grahamslaw
Main trial site:
Liverpool School of Tropical Medicine

A multicentre prospective, observational, longitudinal cohort study in adult patients with suspected upper or lower respiratory infection (URTI/LRTI) to identify a spectrum of biomarkers in exhaled breath to discriminate participants with bacterial RTI from participants without.

Identification of chemical biomarkers in exhaled breath that potentially discriminates participants with bacterial RTI from participants without.

Additional endpoints explored will be variations of the chemical spectrum from all participants using a portable GC-IMS device (Breathspec) stratified by confounding factors, such as (but not limited to) gender, age, antibiotic therapy and smoking status.

 

Local PI

Dr Matt Reed

Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine

Research Team

Fiona McCurrach

Senior Research Nurse

Julia Grahamslaw

Lead Research Nurse

Alison Williams

Senior Research Nurse

Clare Moceivei

Research Nurse- Bank Staff

Caroline Blackstock

AMU Senior Research Nurse

Sian Dalgleish

Senior Research Nurse

Dr Adam Lloyd

Honorary Research Fellow & Lecturer

Emma Moatt

Research Project Manager

More EMERGE Trials

Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.

Read more

IONA Study

Identification of Novel Psychoactive Substances (IONA)

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Read more

ATTEST2 Trial

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)